Three young Italian physicians have earned international recognition at the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, one of the world’s most influential events in cancer research.
Their selection for the prestigious Merit Award highlights not only the quality of Italian medical science, but also the increasingly strong collaboration between Italy and the United States in oncology research.
Among the award recipients is Paolo Ciracì, an oncology resident at the University of Pisa and a research fellow at the Hospital del Mar Research Institute in Barcelona. His work focuses on using artificial intelligence to identify microscopic tumor patterns that can help physicians choose the most effective chemotherapy for patients with metastatic colorectal cancer. His research is part of a broader international network connecting European institutions with leading American cancer centers and data-driven research programs.
Another recognized researcher is Michela Bartolini of Humanitas University and Humanitas Research Hospital in Milan. Her studies explore innovative approaches in precision oncology and immunotherapy, fields in which Italian and American scientists increasingly work side by side through joint clinical trials, scientific exchanges, and multinational research projects.
The third award-winning Italian researcher, Emanuele Crupi, comes from a new generation of physicians working across international research environments that connect Italy with cities such as Chicago, Houston, Los Angeles, and Boston. According to reports from ASCO 2026, the common thread linking these young scientists is their ability to combine Italian medical training with global scientific partnerships.
The recognition is especially meaningful because ASCO attracts more than 40,000 oncology professionals and features over 5,000 scientific abstracts each year. Being honored in such a competitive environment demonstrates how Italian talent continues to contribute to breakthroughs in cancer treatment while maintaining deep connections with American universities, hospitals, and research institutions.
For Italy, these awards represent more than individual achievements. They show how a new generation of researchers is helping strengthen a long-standing scientific bridge between Italy and the United States, turning shared knowledge and innovation into better care for cancer patients worldwide.
